Overview
US laboratory automation company providing modular robotic systems for drug discovery. Cellario software orchestrates multiple robots for high-throughput screening and sample management.
Verified record
- Verified deployments
- None on file
- Active incidents
- None on file
Key facts
Founded
CEO
Product
Customers
Robotics
Patents
Data & sources
Web sources
2
2 sources backing this record.View all →
HighRes Biosolutions on the deployment map
View the global mapHighRes Biosolutions has no verified deployments on the DEPLOY registry yet. Explore the deployment map by place and type.
No verified deployments for HighRes Biosolutions on the DEPLOY record yet. Track HighRes Biosolutions to know the moment the first one is verified.
Current leadership (1)
- Peter Harris ceosecondary-verified
Safety record
No incidents on record for HighRes Biosolutions.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Recent coverage
HighRes Biosolutions in third-party press
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJun 7, 2026
Added to the verified registry
Sources (2)
Common questions
What is HighRes Biosolutions?
What does HighRes Biosolutions make?
Who is the CEO of HighRes Biosolutions?
Where is HighRes Biosolutions headquartered?
Is HighRes Biosolutions a top robotics company?
When was HighRes Biosolutions founded?
Is HighRes Biosolutions safe?
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for HighRes Biosolutions.In the press
Recent coverage mentioning HighRes Biosolutions from third-party publications. Automatically surfaced; not part of the verified registry record.
Inside Recursion’s push for self-driving drug labs with NVIDIA AI - Stock Titan
<a…
Humanoid robots and lab machines attract researchers at SLAS - Chemical & Engineering News
<a…
Novo Nordisk, HighRes Biosolutions collaborate on Lab of the Future - The Robot Report
<a…
How Does Big Pharma Automate its Labs? This Startup is the Answer - The Business Journals
<a…
Beverly pharma robotics company names new CEO - The Business Journals
<a…
Sudden, unexpected demise of Rethink Robotics shakes up automation industry - ZDNET
<a…
HighRes Biosolutions accelerates pharmaceutical research with automation - The Robot Report
<a…
Life Sciences Labs Need Cobots, Not Robots - Genetic Engineering and Biotechnology News
<a…
Using Modular and Mobile Robotic Solutions in The Biotech Industry - Robotics Tomorrow
<a…
Machine-readable surfaces
- Markdown mirror: /companies/highres-biosolutions.md
- RSS feed: /companies/highres-biosolutions/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/2896960c-a6c4-4da4-a186-da6a5136fd80
- Revision history: /companies/highres-biosolutions/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Reality vs attention
Not enough verified signal yet to place HighRes Biosolutions against peers. Reality and attention percentiles publish once the underlying record clears its data floor.
6-month trend
Analysis
Limited public visibility and press coverage relative to peers.
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 6, 2026